Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis | Zendy

Paolo Fanti | Zendy; Tammy Stephenson | Zendy; Ismo M. Kaariainen | Zendy; Butros Rezkalla | Zendy; Yusuke Tsukamoto | Zendy; Tetsuo Morishita | Zendy; Masanori Nomura | Zendy; Chagriya Kitiyakara | Zendy; Laurie J. Custer | Zendy; Adrian A. Franke | Zendy

Open Access

Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis

Author(s) -

Paolo Fanti,

Tammy Stephenson,

Ismo M. Kaariainen,

Butros Rezkalla,

Yusuke Tsukamoto,

Tetsuo Morishita,

Masanori Nomura,

Chagriya Kitiyakara,

Laurie J. Custer,

Adrian A. Franke

Publication year - 2003

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfg229

Subject(s) - medicine , isoflavones , end stage renal disease , kidney disease , disease , physiology , endocrinology

Soya foods, a staple in several Asian countries, have received increasing attention because of their nutritional properties and their high isoflavone content. We have shown recently abnormal pharmacokinetics of soya isoflavones following acute oral intake, in soya-naive end-stage renal disease (ESRD) patients. No information is available, however, about blood levels of soya isoflavones in ESRD patients with habitual soya intake. Additionally, no information is available about the conjugation profile of these compounds in ESRD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research